Global Veterinary Infectious Disease Diagnostics Market Projected to Surpass USD 4.9 Billion by 2033

The global veterinary infectious disease diagnostics market, valued at USD 1.9 billion in 2023, is set to witness substantial growth, projected to exceed USD 4.9 billion by 2033, according to a recent analysis by Future Market Insights (FMI). This growth trajectory reflects a robust compound annual growth rate (CAGR) of 10.1% over the forecast period.

Advancements in diagnostic technologies are pivotal in shaping this expansion. Leading industry players are committed to enhancing customer experiences by leveraging artificial intelligence (AI) algorithms. These innovations empower veterinarians with cost-effective access to expert-level diagnostic insights, remote specialist evaluations, and post-diagnostic consultations, ensuring comprehensive and timely medical decisions.

Report Sample Comprehensive Insights: https://www.futuremarketinsights.com/reports/sample/rep-gb-14276

“Our commitment is to empower veterinarians as our partners in animal healthcare,” remarked a FMI. “We tailor our solutions to seamlessly integrate into existing protocols, enhancing diagnostic precision and treatment efficacy across diverse therapeutic segments.”

Key offerings include advanced veterinary microbiology solutions tailored for veterinary labs, encompassing high-quality culture mediums, identification tools, susceptibility testing items, and automated Johne’s Disease instruments and reagents. These innovations cater to a wide range of species treated in veterinary medicine, supported by thousands of pharmacological, biological, nutritional, and diagnostic products.

“Our multinational presence allows us to address unique regional challenges,” added the FMI. “By aligning our products and services with the needs of veterinarians, farmers, and pet owners worldwide, we ensure practical and effective solutions that enhance treatment adherence and animal welfare globally.”

Key Takeaways:

• During the anticipated period, the United States is anticipated to lead the global veterinary infectious disease diagnostics market. In the United States, veterinary diagnostics are meant to assist veterinarians utilize medicines wisely, while also developing methods to combat animal diseases and zoonoses.
• Japan is predicted to dominate the Asia Pacific veterinary infectious diseases diagnostics market throughout the forecast period. In order to improve animal health, major firms in Japan are offering diagnostic services using modern technology to identify novel ailments, particularly exotic diseases. In response to requests from the national and local governments of Japan, this is carried out.
• Owing to its increasing sales and the rising occurrence of animal illnesses, the “immunodiagnostics” technology type is expected to hold the greatest revenue through the forecast period.
• As pet popularity increases and pet insurance becomes more widely used, the “companion animal” animal type, and is the most creative segment for key companies, accounting for a sizable portion.

Customization with Our Report: https://www.futuremarketinsights.com/customization-available/rep-gb-14276

Competitive Landscape:

The global veterinary infectious disease diagnostics market share is fragmented as a result of both domestic and international competitors. Several companies command substantial market shares in their respective specialty areas. Large corporations generally give natural events like product approvals and the rise in pet adoption around the world a significant amount of importance. The market for veterinary infectious disease diagnostics is predicted to expand quickly as a result of these factors.

Key Players:

• Zoetis Inc.
• Thermo Fisher Scientific
• Virbac
• Biomerieux SA
• Heska Corporation
• IDvet
• NEOGEN Corporation
• QIAGEN N.V.
• Randox Laboratories Ltd.

Recent Developments:

• In September 2018, Equine Progesterone, a test for determining the progesterone level in horses, was released, according to Eurolyser Diagnostica GmbH.
• In January 2019, the Catalyst One and Catalyst Dx analyzers, an in-house testing technique for the measurement of progesterone levels in dogs, were launched by IDEXX Laboratories, Inc.

Key Segments Profiled in the Veterinary Infectious Disease Diagnostics Market Survey:

By Technology:

• Immunodiagnostics
• Molecular Diagnostic
• Others

By Animal Type:

• Companion Animal
• Food-producing Animals

By End User:

• Reference Laboratories
• Veterinary Hospitals & Clinics
• Point-of-Care
• Research Institutes & Universities

By Region:

• North America
• Latin America
• Asia Pacific
• MEA
• Europe

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube